Who is sponsoring NCT03656523?

NCT03656523 is sponsored by Heart Care Foundation.

What drugs are being tested in NCT03656523?

Interventions in NCT03656523: Acute coronary syndrome and PCI and AF.

What condition does NCT03656523 study?

NCT03656523 studies Acute Coronary Syndrome, Atrial Fibrillation.

Is NCT03656523 still recruiting?

NCT03656523 is currently completed. Last updated 3 February 2021.

Last reviewed 2021-02-03 · How we verify

NCT03656523: Matador-PCI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI

Completed Last updated 3 February 2021

What this trial tests

trial testing Acute coronary syndrome and PCI and AF in Acute Coronary Syndrome in 598 participants. Completed in 17 August 2020.

Timeline

25 July 2018

Primary endpoint
17 August 2020

17 August 2020

Quick facts

Lead sponsor	Heart Care Foundation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	598
Start date	25 July 2018
Primary completion	17 August 2020
Estimated completion	17 August 2020
Sites	76 locations across Italy

Drugs / interventions tested

Acute coronary syndrome and PCI and AF

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Heart Care Foundation

Who can join

18 and older, any sex, with Acute Coronary Syndrome or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ACS are a potent risk factor for AF, with new onset AF occurring in up to 1 in every 5 patients hospitalized with an ACS. Despite its relatively frequent occurrence and the many etiologic factors involved in its pathogenetic condition, the frequency and prognostic significance of AF complicating ACS remain unclear

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study.
De Luca L, Rubboli A, Bolognese L, Gonzini L, et al · · 2020 · cited 12× · PMID 33371033 · DOI 10.1136/bmjopen-2020-041044

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other Heart Care Foundation trials

Trials by the same sponsor.

NCT07252388 — EARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention · NA · not yet recruiting
NCT07283809 — European Unified Registries for Heart Care Evaluation and Randomised Trials Italy · recruiting
NCT06775028 — Integrated Approach in Frail Older People with Atrial Fibrillation · NA · recruiting
NCT06316128 — EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs · completed
NCT06279988 — BRING-UP 3 Heart Failure · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03656523 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heart Care Foundation
Last refreshed: 3 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03656523.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing